about
Where is biological therapy going?Cell-cell interactions in synovitis. Interactions between T lymphocytes and synovial cellsRegulation and localization of endogenous human tristetraprolinAnti-cytokine therapy in chronic destructive arthritisPreparing the first responders: building the inflammatory transcriptome from the ground upHeat shock protein bystander antigens for peptide immunotherapy in autoimmune diseaseClinical biomarkers and pathogenic-related cytokines in rheumatoid arthritisThe IL1 -S100A13 Heterotetrameric Complex Structure: A COMPONENT IN THE NON-CLASSICAL PATHWAY FOR INTERLEUKIN 1 SECRETIONSulphasalazine inhibits macrophage activation: inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expressionAnti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in miceInduction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responsesDifferential activation of endocrine-immune networks by arthritis challenge: Insights from colony-specific responsesWhat are the most promising strategies for the therapeutic immunomodulation of allergic diseases?Evaluation of Protective Efficacy of Avicennia marina (Forssk.) Vierh Leaves against Complete Freund᾽s Adjuvant-induced Arthritis in Wistar.TNF alpha blockade in rheumatoid arthritis--time for caution or enthusiasm?Effect of inflammation on lacrimal gland function.Anticytokine therapy for osteoarthritis.Novel therapies in vasculitis.Developments in the treatment of uveitis.Anti-inflammatory and Anti-arthritic Effects of a Novel Leflunomide Analogue, UTL-5b (GBL-5b).VEGF and imaging of vessels in rheumatoid arthritisMolecular-based therapeutic approaches in treatment of anorexia of aging and cancer cachexia.Role of caspases in TNF-mediated regulation of cPLA(2).Lipid extract from hard-shelled mussel (Mytilus coruscus) improves clinical conditions of patients with rheumatoid arthritis: a randomized controlled trial.Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha productionInhibition of interleukin-12 production by auranofin, an anti-rheumatic gold compound, deviates CD4(+) T cells from the Th1 to the Th2 pathwayCacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor-alpha by inhibiting nuclear factor-kappa B activation.Calcineurin inhibitors exert rapid reduction of inflammatory pain in rat adjuvant-induced arthritis.Cytokine signalling and disease.Gene polymorphisms, inflammatory diseases and cancer.Gene therapy for arthritis.Distinct effects of anti-tumor necrosis factor combined therapy on TH1/TH2 balance in rheumatoid arthritis patientsSafety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis.Antibodies against cyclic citrullinated peptide don't decrease after 6 months of infliximab treatment in refractory rheumatoid arthritis.Atopic disorders in ankylosing spondylitis and rheumatoid arthritis.Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvementInfliximab treatment reduces complement activation in patients with rheumatoid arthritis.Human cellular inflammation in the pathology of acute cerebral ischaemiaThe shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis populationDrugs that block tumour necrosis factor: experience in patients with rheumatoid arthritis.
P2860
Q24792345-43EF13DA-2DAC-4D13-AED8-CF69AEF98E7AQ24792523-A22940D2-B3D8-4B2D-B8F1-518915FC1061Q24805049-26D09D51-AAA2-4D2D-81A4-D1A4E484F1B1Q24805245-A2029B7C-BA86-433A-8F04-16E9ADAE5205Q26849425-5CE67A4F-7E2D-4541-AE02-123109BC90A4Q27008837-0B66ED77-2C99-43E2-9AC6-7584DD2280DEQ27022559-4554479F-FC91-42C3-A9D7-149BD965D904Q27666745-A77F421A-178B-4E67-AD87-2EC7F8513908Q28347747-D246B92C-63E2-4008-922F-1198D83B58B6Q28472242-A63CB57D-AD20-4F4B-9D98-23D7E0624281Q30732295-EF216F04-241F-40A6-99DF-6E2767CA9FC6Q33673998-7680A230-E787-4713-AAB6-01CCC2655E17Q34190563-27FD54C0-62BC-485D-9A98-01A8CEC566EFQ34256337-520FEC90-D4FB-449E-AF1B-C72B0CCA79C9Q34334556-8D156B43-9D8D-4731-A389-919078CEFF29Q34338027-8344E84B-AB17-4AE4-BAA2-82DAE0485C0DQ34452635-CEAE3383-DAE9-4BB5-8431-9F1411B0CF9DQ34481560-EF2A990B-48E3-4FB3-9C39-2F66434DCD91Q34481964-947CFA25-55E8-485F-8F11-58E40DE0E70FQ34497665-D2225807-7B17-4661-9519-4E4206C6F722Q34731141-8C982C3A-4264-4587-82AB-AAA35EE56A36Q34764949-8511C945-6F20-4A21-9967-CBE8E47C3041Q34980674-FB41659D-64D3-407F-A5EE-DE73415FC6AFQ35003879-A3B6A27E-31BA-4852-98DE-A4A88ABEE3A1Q35023969-3FAC94E7-CB53-44CB-917D-77E9A92B8CB4Q35043799-46D6C1F9-87CD-4DF6-BCA8-3454529935CDQ35045215-D23AAEDA-8E65-4E77-BCC2-1A136A26C3FBQ35045452-5FF17622-5CDD-4DFD-9B5B-542207DCDF8FQ35050409-C6A2E5DE-3C60-4E4B-B0CF-16E3468F210CQ35105502-F31544A9-769B-497C-BE2A-5EB3A6AA8ACCQ35122176-963967F3-896F-444E-AEEB-EFB172B18D91Q35138666-674067BF-5308-4787-83CF-2A7D9D078409Q35194346-44C2FBF8-57F8-4D78-94C8-A9514BEB6FF0Q35475541-03D15100-4B2F-4178-939F-E5C85DD079B6Q35551083-77D7A006-CDFE-4446-8C31-E8C1CAB60FE7Q35553375-DC9ACDBC-83C8-44F3-B56B-17611BB5BD99Q35555743-88DD582F-40A6-4A1C-9C7D-4420C9011EE6Q35583807-0E256034-B4A9-4808-9B7C-C0BEB4B55043Q35636836-B55DCE6D-F187-4B00-B589-A76BC1E05F8BQ35780354-D747E819-AA5F-4E67-A9F1-537FCB266CD6
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Anti-cytokine therapy for rheumatoid arthritis.
@ast
Anti-cytokine therapy for rheumatoid arthritis.
@en
type
label
Anti-cytokine therapy for rheumatoid arthritis.
@ast
Anti-cytokine therapy for rheumatoid arthritis.
@en
prefLabel
Anti-cytokine therapy for rheumatoid arthritis.
@ast
Anti-cytokine therapy for rheumatoid arthritis.
@en
P1476
Anti-cytokine therapy for rheumatoid arthritis.
@en
P2093
P304
P356
10.1146/ANNUREV.MED.51.1.207
P577
2000-01-01T00:00:00Z